The Importance of Communication with Customers in Supply Chain of Pharmaceutical Market of Uzbekistan

Aziz Khamzaev


Communication with consumers plays an essential role in the supply of in–demand medicines. In this article an extensive overview of the literature on the problem is made, the author, based on personal experience in the supply chain of medicines, provides a valid argumentation of the relevance and significance of this communication. Based on the analysis of the pharmaceutical industry of Uzbekistan the author draws his own conclusions and recommendations.


Pharmaceutical Market; Supply Chain; Customers; Communication; Medicine; Pharmacist; Drugs; Pharmaceutical Industry

Full Text:



Ahmedov, M. et al., 2014. Uzbekistan Health system review. Health Systems in Transition, 16 (5). – p. 1–137.

Makhmudova, M. M., 2020. Studying the history of the development of the healthcare system in Uzbekistan during the years of independence. Current research journal of history, 2(5). – p. 31–35.

SZABÓ–GELETÓCZKI, R., KOZMA, T. & PÓNUSZ, M., 2022. Market Changes in the Pharmaceutical Industry. European and Regional Studies, Volume 22. – p. 50–72.

Basuki, M., 2021. Supply chain management: a review. Journal of Industrial Engineering and Halal Industries, 2(1). – p. 2–12.

Yang, X. et al., 2022. Pricing Problems in the Pharmaceutical Supply Chain with Mixed Channel: A Power Perspective. Sustainability, Volume 14. – p. 1–20.

Venkateswaran, N., 2018. Logistics information system (list) at pharma firm–an evaluation. International Journal of Business and General Management, 7(3). – p. 11–18.

WHO, 2021. Uzbekistan strengthens its health system in the midst of COVID–19 crisis. [Accessed 2 March 2023].

Yang, C. et al., 2016. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study. PLOS ONE, 11(10). – p. 1–16.

Vogler, S., 2012. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries–an overview. Generics and Biosimilars Initiative Journal (GaBI Journal), 1(2). – p. 93–100.

Sun, J. et al., 2018. A review of promoting access to medicines in China–problems and recommendations. BMC Health Services Research, Volume 18. – p. 2–9.

Dremova, N. B. & Solomka, S.V., 2022. WOR.

LD Pharmaceutical Market: Trendwatching. Laboratory and Clinical Medicine. Pharmacy, 2(1). – p. 56–68.

Morley, M., 2017. Supply Chain Analytics for Dummies. Chichester, West Sussex: John Wiley and Sons, Ltd.

Yousefi, N. & Alibabaei, A., 2015. Information Flow in the Pharmaceutical Supply Chain. Iranian Journal of Pharmaceutical Research, 14(4). – p. 1299–1303.

Musayeva, S. A. & Marufov, Z.A., 2022. Features of the pharmaceutical market of the Republic of Uzbekistan. International Journal of Social Science & Interdisciplinary Research (IJSSIR), 11(6). – p. 201–206.

U PHARMA, 2021. Uzbekistan Pharmaceutical Country Report 2021, Kyiev: UPHARMA Consulting.

Abdurakhmonov, J.U. & Voronina, O.M., 2017. Research of the pharmaceutical market of Uzbekistan and prospects of its development. Kharkov. Topical issues of new drugs development: abstracts оf XXIV international scientific and practical conference of young scientists and student.

DrugAudit, 2022. Information about certified medical products in Uzbekistan, Tashkent: Yevro Farmis.

Central Bank of Uzbekistan, 2023. Archives of Exchange Rates. [Accessed 2 March 2023]. [Accessed 2 April, WHO, 2021].

WHO, E.R., 2023. Availability and prices of essential medicines, Copenhagen: WHO Regional Office for Europe.



  • There are currently no refbacks.

Copyright (c) 2023 International Journal of Multicultural and Multireligious Understanding

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Multicultural and Multireligious Understanding (IJMMU) ISSN 2364-5369
Copyright © 2014-2018 IJMMU. All rights reserved.